Related Experiment Video
Updated: Jun 12, 2026
06:51
A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
Thrombosis in children with hematologic malignancies
Rosemarie Schobess1, Beate Kempf-Bielack, Dirk Schwabe
1Department of Pediatrics, University of Halle, Germany.
Reviews in Clinical and Experimental Hematology
|July 21, 2005
Summary
Pediatric acute lymphoblastic leukemia patients with prothrombotic risk factors may develop venous thrombosis due to prednisone and E. coli asparaginase treatment. Preventive anticoagulant strategies are discussed.
Area of Science:
- Pediatric Hematology
- Oncology
- Thrombosis Research
Background:
- Symptomatic thrombosis is a concern in children with hematologic malignancies.
- Acquired and inherited prothrombotic risk factors increase this risk.
- Treatment protocols, including chemotherapy, interact with these risk factors.
Purpose of the Study:
- To review pediatric reports on thrombosis in children with hematologic malignancies.
- To discuss the interplay of treatment, risk factors, and thrombosis.
- To suggest potential preventive strategies for thrombosis.
Main Methods:
- Literature review of pediatric reports up to January 2004.
- Analysis of symptomatic thrombosis cases in children with hematologic malignancies, primarily acute lymphoblastic leukemia.
- Discussion of various prothrombotic risk factors (genetic and acquired) and treatment modalities.
Main Results:
- Prednisone and E. coli asparaginase administered together appear to be a significant factor in venous thrombosis onset in leukemic patients with prothrombotic risk factors.
- Interactions between treatment, study design, ethnicity, and central venous catheters are considered.
- The review highlights the complexity of thrombosis development in this patient population.
Conclusions:
- Concomitant administration of prednisone and E. coli asparaginase is implicated in the majority of venous thrombosis cases in pediatric leukemia patients with prothrombotic risk factors.
- Primary preventive anticoagulant or antithrombotic strategies should be considered.
- Further research into risk stratification and tailored preventive measures is warranted.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...